Tag Archives: BRCA2

Next generation sequencing, a new gold standard for clinical gene panel testing

The adaption of the Next Generation Sequencing ( NGS ) technology to clinical laboratories has revolutionized the molecular diagnostics by reducing the costs and increasing the throughput. Clinical use of NGS enables simultaneous testing of multiple genes

Focusing on the most relevant gene variants in inherited breast and ovarian cancer

Modern sequencing technology (which has begun to become adopted in clinical labs) can provide invaluable genetic information of individuals, such as those with a family history of early onset breast cancer. However, this information also results in